![22411298](https://user-images.githubusercontent.com/22411298/83512337-b17a2d00-a4ed-11ea-85c8-ef890e47a826.png)
## Atanu Bhattacharjee,Ph.D (Statistics)
Assistant Professor Biostatistics
Centre for Cancer Epidemiology, Tata Memorial Centre, India
## Biography
I am working as Assistant Professor Biostatistics in the Section of Biostatistics, Centre for Cancer Epidemiology, Tata Memorial Centre, Mumbai.I am also an Ajunct Professor of Statistics at Department of Applied Mathematics, Indian Institute of Technology-Dhanbad. I completed by Ph.D in statistics under the supervision of Dr. Dilip C Nath.
My research interests include Bayesian inference, longitudinal data analysis, survival analysis, gene expression data analysis.

## Ph.D Awarded
1. Abin Thomas 2021 Ph.D thesis "Modeling of Gene Expression for Cancer Biomarkers using Bayesian Frarmework".

## Editorial 
Review Editor of Computation Genomics
Previous Associate Editor, British Medical Central-Research Methodology.
Plos One, Applied Statistics


## Book Publication
1.Atanu Bhattacharjee (2021).Bayesian Approaches in Oncology Using R and OpenBUGS.CRC press.https://www.routledge.com/Bayesian-Approaches-in-Oncology-Using-R-and-OpenBUGS/Bhattacharjee/p/book/9780367350505.


2. Atanu Bhattacharjee (2013).Bayesian Analysis in Longitudinal Data. Lambert Publication.
### Chapters in Book
Gaurav Roy, Atanu Bhattacharjee, and Iqra Khan (2020).‘Essentials of Cancer Genomic,
Computational Approaches and Precision Medicine. Spinger Verlag, Nature.

3.Special Issue:Biostatistics in Oncology.Volume 3, Issue 4
August 2020
Issue Edited by: 
Atanu Bhattacharjee, in Cancer Reports. https://onlinelibrary.wiley.com/toc/25738348/2020/3/4

## Developed R packages listed in CRAN
### (I)https://cran.r-project.org/web/packages/SurvHiDim/index.html
[SurvHiDim.pdf][SurvHiDim_0.1.0.tar.gz](https://github.com/AtanuBhattacharjee/github.io/files/6515625/SurvHiDim_0.1.0.tar.gz)


### (II)https://cran.r-project.org/web/packages/longit/index.html[longit.pdf]
[longit_0.1.0.tar.gz](https://github.com/AtanuBhattacharjee/github.io/files/6515622/longit_0.1.0.tar.gz)

### (III)https://cran.r-project.org/web/packages/SurviMChd/index.html[SurviMChd_0.1.0.pdf]
[SurviMChd_0.1.0.tar.gz](https://github.com/AtanuBhattacharjee/github.io/files/6528145/SurviMChd_0.1.0.tar.gz)


### (IV) https://cran.r-project.org/web/packages/autohd/index.html
[autohd.pdf][autohd_0.1.0.tar.gz](https://github.com/AtanuBhattacharjee/github.io/files/6515618/autohd_0.1.0.tar.gz)


### (V)https://cran.r-project.org/web/packages/highMLR/index.html
[highMLR_0.1.0.tar.gz](https://github.com/AtanuBhattacharjee/github.io/files/6515602/highMLR_0.1.0.tar.gz)

### (VI)https://cran.r-project.org/web/packages/afthd/index.html
[afthd_0.1.0.tar.gz](https://github.com/AtanuBhattacharjee/github.io/files/6575905/afthd_0.1.0.tar.gz)

### (VII)https://cran.r-project.org/web/packages/MIIPW/index.html
[MIIPW_0.1.0.tar.gz](https://github.com/AtanuBhattacharjee/github.io/files/6706146/MIIPW_0.1.0.tar.gz)

## Contribution to Science
Complete List of Published Work in My Bibliography:
https://www.ncbi.nlm.nih.gov/myncbi/atanu.bhattacharjee.1/bibliography/public/
## Research Paper
### [2021]
1. Gajendra K. VISHWAKARMA,Atanu BHATTACHARJEE, Sharvari SHUKLAdTürkiye.
COVID-19 Mortality Prediction:An Algorithm by Bayesian Autoregressive Model.Klinikleri Biyoistatistik Dergisi.Turkiye Klinikleri J Biostat. 2021;13(2):178-84.DOI: 10.5336/biostatic.2020-80264

1.Ashwini Kalshetty, Biju Menon, Sutapa Rakshit, Atanu Bhattacharjee and Sandip Basu. Correlation of lesional uptake parameters and ratios with miPSMA score and estimating normal physiological concentration: an exploratory analysis in mCRPC patients with 68Ga-PSMA-11 PET-CT. Journal of Nuclear Medicine Technology July 2021, jnmt.120.261289; DOI: https://doi.org/10.2967/jnmt.120.261289.
2. Jesna Jose,Gajendra K.Vishwakarma, AtanuBhattacharjee.Illustration of Missing Data Handling Technique Generated from Hepatitis C Induced Hepatocellular Carcinoma Cohort Study. Journal of King Saud University - Science,Available online 26 March 2021, 101403.[1-s2.0-S1018364721000641-main.pdf][1-s2.0-S1018364721000641-main (1).pdf](https://github.com/AtanuBhattacharjee/github.io/files/6289214/1-s2.0-S1018364721000641-main.1.pdf)

3. Sharma PJ, Mahajan A, Rane S, Bhattacharjee A. Assessment of COVID-19 severity using computed tomography imaging: A systematic review and meta-analysis. Cancer Research, Statistics, and Treatment. Cancer Res Stat Treat 2021;4:78-87. [CancerResStatTreat4178-3984416_110404.pdf](https://github.com/AtanuBhattacharjee/github.io/files/6211327/CancerResStatTreat4178-3984416_110404.pdf)

4.Atanu Bhattacharjee, Arti Hole, Akshat Malik, Aditi Sahu, S P Singh, Atul Deshmukh, Sudhir Nair,Pankaj Chaturvedi,Murali Krishna.Risk prediction by Raman spectroscopy for disease-free survival in oral cancers. Lasers in Medical Science.Lasers Med Sci .2021 Mar 4. doi: 10.1007/s10103-021-03276-3.  

5.Effect of Early Palliative Care on Quality of Life of Advanced Head and Neck Cancer Patients: A Phase III Trial.Vijay Maruti Patil, MBBS, MD, DM, Pankaj Singhai, MBBS, MD, Vanita Noronha,Atanu Bhattacharjee, Jayita Deodhar,Naveen Salins,Amit Joshi, Nandini Sharrel Menon,Anuja Abhyankar, Ashwini Khake,Sachin Babanrao Dhumal,Rupali Tambe, Bcom, Mary Ann Muckaden,Kumar Prabhas. JNCI: Journal of the National Cancer Institute, djab020, https://doi.org/10.1093/jnci/djab020.

6.Vedang Murthy, Ganesh Bakshi, Jifmi Jose Manjali, Gagan Prakash, Mahendra Pal, Amit Joshi,  Kunal Dholakia, Atanu Bhattacharjee, Sanjay Talole, Abhinav Puppalwar,  Shashank Srinivasan,Gitanjali Panigrahi,Rohan Salunkhe,Santosh Menon, Vanita Noronha, Kumar Prabhash, Rahul Krishnatry.Locoregional recurrence after cystectomy in muscle invasive bladder
cancer: Implications for adjuvant radiotherapy.Orologic Oncology: Seminar and Original Investigation 000(2021) 1-7.https://doi.org/10.1016/j.urolonc.2021.01.015[1-s2.0-S1078143921000156-main.pdf](https://github.com/AtanuBhattacharjee/github.io/files/5949604/1-s2.0-S1078143921000156-main.pdf)

7. Gajendra K. Vishwakarmaa,Abin Thomas and Atanu Bhattacharjee.A weight function method for selection of proteins to predict an outcome using protein expression data
Journal of Computational and Applied Mathematics.GajendraK.VishwakarmaAbinThomasAtanuBhattacharjee[1,2][3][4][4–6][7][8,9][10][11–14]
 [1-s2.0-S0377042721000844-main.pdf](https://github.com/AtanuBhattacharjee/github.io/files/5979333/1-s2.0-S0377042721000844-main.pdf)

8. Jesna Jose, Hasan M. Al-Dorzi, Awad Al-Omari, Yasser Mandourah, Fahad Al-Hameed, Musharaf Sadat, Eman Al Qasim, Basem Alraddadi, Abdulrahman Al Harthy, Ghaleb A. Al Mekhlafi, Abdullah Almotairi, Kasim Al Khatib, Ahmed Abdulmomen, Ismael Qushmaq, Anees A. Sindi, Ahmed Mady, Othman Solaiman, Rajaa Al-Raddadi, Khalid Maghrabi, Ahmed Ragab, Ayman Kharaba, Sarah Shalhoub, Abdulsalam M. Al-Aithan, Gajendra K. Vishwakarma, Atanu Bhattacharjee, Yaseen M. Arabi .Critically ill patients with diabetes and Middle East respiratory syndrome: a multi-center observational study. [s12879-021-05771-y.pdf](https://github.com/AtanuBhattacharjee/github.io/files/5899190/s12879-021-05771-y.pdf).

9.Bayesian Competing Risk Analysis: An Application to Nasopharyngeal Carcinoma Patients data( In press)Computational and Systems Oncology.[cso2.1006.pdf](https://github.com/AtanuBhattacharjee/github.io/files/5763432/cso2.1006.pdf).Comput Syst Oncol.2020.1:e1006.
### [2020]

1.Monika Rajput, Mukesh Kumar, Mayuri Kumari, Atanu Bhattacharjee, Aanchal Anant Awasthi.Identification of key genes and construction of regulatory network for the progression of cervical cancer. gene reports(2020).[1-s2.0-S2452014420303794-main.pdf](https://github.com/AtanuBhattacharjee/github.io/files/5594233/1-s2.0-S2452014420303794-main.pdf)


2.Gajendra K. Vishwakarma,Atanu Bhattacharjee,Souvik Banerjeea.Handling Missingness Value on Jointly Measured Time-Course and Time-to-event Data [Handling missingness value on jointly measured time course and time to event data.pdf](https://github.com/AtanuBhattacharjee/github.io/files/5658367/Handling.missingness.value.on.jointly.measured.time.course.and.time.to.event.data.pdf)


3.Vijay PatilVanita NoronhaSachin Babanrao DhumalAmit JoshiNandini MenonAtanu Bhattacharjee and et al. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial. www.thelancet.com/lancetgh.

4.Atanu Bhattacharjee1,Gajendra K.Vishwakarma,Souvik Banerjee and Sharvari Shukla. Disease progression of cancer patients
during COVID-19 pandemic: a comprehensive analytical strategy by timedependent modelling.BMC Medical Research Methodology (2020) 20:209.[Bhattacharjee_et_al-2020-BMC_Medical_Research_Methodology.pdf](https://github.com/AtanuBhattacharjee/github.io/files/5070215/Bhattacharjee_et_al-2020-BMC_Medical_Research_Methodology.pdf)



5.Gajendra K. Vishwakarma,Atanu Bhattacharjee,Souvik Banerjee,Benoit Liquet. Classification Algorithm for High Dimensional Protein Markers in Time-course Data. Accepted in Statistics in Medicine.[10.1002@SIM.8720.pdf](https://github.com/AtanuBhattacharjee/github.io/files/5569677/10.1002%40SIM.8720.pdf)



6.Atanu Bhattacharjee, Gajendra Vishwakarma and Souvik Banerjee.Joint Modeling of Longitudinal and Time-to-Event Data with Missing Time-Varying Covariates in Targeted Therapy of Oncology.Communications in Statistics: Case Studies, Data Analysis and Applications.[Joint modeling PCR.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4867678/Joint.modeling.PCR.pdf).

7.Atanu Bhattacharjee. Estimation of Treatment Effect with Missing Observations for Three Arms and Three Periods Crossover Clinical Trials.(In Press). Annals of Data Science.https://rdcu.be/b5bPM[ADS.pdf][10.1007_s40745-020-00303-y.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4941078/10.1007_s40745-020-00303-y.pdf)



8.Sandip Basu,Atanu Bhattacharjee and Beju Menon. "Standardized Uptake Values and Ratios on 68Ga-DOTATATE PET-CT for Normal organs and Malignant Lesions and their correlation with Krenning Score in patients with Metastatic Neuroendocrine tumors"(In press). Nuclear Medicine Communications.[NMC.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4867694/NMC.pdf)


9.Hitesh Rajendra Singhavi,Arjun Singh,Atanu Bhattacharjee,Sanjay Talole,Rajesh Dikshit,Pankaj Chaturvedi. Alcohol and Cancer Risk: A Systematic Review and Meta‑Analysis of Prospective Indian Studies.June 2020Indian journal of public health 64(2):186-193
[IndianJPublicHealth642186-6212962_171529.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4788130/IndianJPublicHealth642186-6212962_171529.pdf)


10.Patil, V. M., Noronha, V., Joshi, A., Talreja, V., Dhumal, S., Menon, N., ... & Prabhash, K. (2020). Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy. Cancer Research, Statistics, and Treatment, 3(2), 201.

11.Atanu Bhattacharjee,Mukesh Kumar,Kamalesh Kumar Patel. When COVID-19 will Decline in India? Prediction by Combination of Recovery and
Case Load Rate.[[CEGH Published.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4840778/CEGH.Published.pdf)](https://github.com/AtanuBhattacharjee/github.io/files/4751985/preprints202005.0044.v1.pdf)

12.Atanu Bhattacharjee,GajendraK.Vishwakarma,Souvik Banerjee and Sharvari Shukla.How to Analyze Cancer Progression in COVID-19 Pandemic?
[v1_stamped.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4751930/v1_stamped.pdf).

13.Nimisha Tripathi, Sneha Keshari, Pallavi Shahi, Poonam Maurya, Atanu Bhattacharjee, Kushal Gupta, Sanjay Talole, Mekesh Kumar.Human papillomavirus elevated genetic biomarker signature by statistical algorithm.Journal of Cellular Physiology(In press).[JCP Published Article.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4779762/JCP.Published.Article.pdf)

14.Arun Balaji, Shivakumar Thiagarajan, Harsh Dhar, Akshat Malik, Atanu Bhattacharjee, Adhara Chakraborthy,Snehal Shah, et al.The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies.European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-020-06105-5
[10.1007_s00405-020-06105-5.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4752458/10.1007_s00405-020-06105-5.pdf)


15.Nikita Singh,Mukesh Kumar,Atanu Bhattacharjee,Prashant Kumar Sonker,Agni Saroj.Identification of Biomarkers and Enriched Pathways Involved in Lung Cancer.
[preprints2020NCC.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4751966/preprints2020NCC.pdf)

16.Abin Thomas,Gajendra K.Vishwakarma and Atanu Bhattacharjee.Joint modeling of longitudinal and time-to-event data on multivariate protein biomarkers.https://doi.org/10.1016/j.cam.2020.113016.[1-s2.0-S0377042720303071-main.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4737433/1-s2.0-S0377042720303071-main.pdf)

17.Atanu Bhattacharjee,Subita Patil,Sanjay Talole,Arjun Singh,Pankaj Chaturvedie,Rajesh Dikshit.An impact of single prevalence rate reduction of tobacco on cancer incidence- A challenge for global policy maker.https://doi.org/10.1016/j.cegh.2020.04.029.[pagination_CEGH_583.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4714852/pagination_CEGH_583.pdf).

18.Vijay M. Patil  Arti Bhelekar  Nandini Menon  Atanu Bhattacharjee  Vijai Simha  Ram Abhinav  Anuja Abhyankar  Epari Sridhar  Abhishek Mahajan  Ameya D. Puranik. Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma.cancer Medicine.https://doi.org/10.1002/cam4.3094.[2020I.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716315/2020I.pdf)

19.Atanu Bhattacharjee, Vijay M Patil, Rajesh Dikshit, Kumar Prabhash, Arjun Singh, Pankaj Chaturvedi.Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.Head Neck
.2020 Jun;42(6):1173-1178. doi: 10.1002/hed.26196. Epub 2020 Apr 28.[2020G.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716313/2020G.pdf)


20.Atanu Bhattacharjee, Jacinth Rajendra, Rajesh Dikshit, Shilpee Dutt.HER2 borderline is a negative prognostic factor for primary malignant breast cancer.Breast Cancer Res Treat. 2020 May;181(1):225-231. doi: 10.1007/s10549-020-05608-3.[2020F.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716308/2020F.pdf)

21.Atanu Bhattacharjee.Bayesian competing risks analysis without data stratification.DOI:https://doi.org/10.1016/j.cegh.2019.08.010.[2020E.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716303/2020E.pdf)

22.Akshat Malik,Sudhir Nair,Arjun Singh,Komal Lamba,Swapnil Rane,Munita Bal,Atanu Bhattacharjee,Hisham Mehanna, Pankaj Chaturvedi.Soft tissue deposit in neck dissection specimen carries a poor prognosis in oral cancer: A matched pair analysis.https://doi.org/10.1002/hed.26103. [2020A.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716274/2020A.pdf)

23.Vanita Noronha,Vijay Maruti Patil,Amit Joshi,Manoj Mahimkar,Usha Patel,Manish Kumar Pandey,Arun Chandrasekharan,Hollis Dsouza,Atanu Bhattacharjee,Abhishek Mahajan,Nilesh Sabale,Jai Prakash Agarwal,Sarbani Ghosh-Laskar,Ashwini Budrukkar,Anil K D'Cruz,Pankaj Chaturvedi ,Prathamesh S Pai,Devendra Chaukar, Sudhir Nair,Shivakumar Thiagarajan,Shripad Banavali,Kumar Prabhash.
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer. Oncotarget
. 2020 Jan 28;11(4):399-408. doi: 10.18632/oncotarget.27443.[2020B.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716284/2020B.pdf)

24.Vanita Noronha,Atanu Bhattacharjee,Vijay M Patil,Amit Joshi,Nandini Menon,Srushti Shah,Sadhana Kannan,Sadaf A Mukadam, Kamesh Maske, Sandeep Ishi, Kumar Prabhash.Aprepitant for Cough Suppression in Advanced Lung Cancer: A Randomized Trial.Chest
. 2020 Jan 18;S0012-3692(20)30032-5. doi: 10.1016/j.chest.2019.11.048.[2020C.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4729558/2020C.pdf)


25.Vijay Maruti Patil,Vanita Noronha,Shivakumar Thiagarajan,Amit Joshi,Arun Chandrasekharan,Vikas Talreja,Jaiprakash Agarwal,Sarbani Ghosh-Laskar,Ashwini Budrukkar,Shashikant Juvekar,Abhishek Mahajan,Archi Agarwal,Nilendu Purandare,Atanu Bhattacharjee, Anil K D'Cruz, Pankaj Chaturvedi,Prathamesh S Pai 2,Devendra Chaukar,Kumar Prabhash.Salvage surgery in head and neck cancer: Does it improve outcomes?Eur J Surg Oncol. 2020 Jan 15;S0748-7983(20)30024-X. doi: 10.1016/j.ejso.2020.01.019.[2020D.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716296/2020D.pdf)

26.Vijay M. Patil, Vanita Noronha, Amit Joshi,Vikas Talreja, Sachin Dhumal, Nandini Menon,Anuja Abhyankar, Hollis Dsouza,Gunjesh Kumar Singh, Atanu Bhattacharjee,Sarbani Ghosh‑Laskar,Prathamesh Pai,Pankaj Chaturvedi,Deepa Nair,Devendra Chaukar3, Anil D’Cruz,Prakash Shetty3, Aliasgar Moiyadi,Kumar Prabhash.Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy.Cancer Res Stat Treat 2020;3:201-6.[2020T.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4804031/2020T.pdf)
 

## [2019]
1. Amit Joshi, Sameer Shrirangwar, Vanita Noronha, Nilesh Sable, Archi Agarwal, Palak Popat, Atanu Bhattacharjee, Kumar Prabhash.
 A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer.
 Asian J
Cancer 2020;9:23-6.
2. Thiagarajan S, Dhar H, Bhattacharjee A, Fatehi KS, Shah SB, Chaukar D, Nair D, Deshmukh A, Prabhash K, Joshi A, Patil V, Noronha V, Laskar SG, Cruz AKD.Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to Neo-Adjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis.Oral Oncol. 2019 Nov 15;100:104455. doi: 10.1016/j.oraloncology.2019.104455.
3. Narasimhan M, Kannan S, Chawade A, Bhattacharjee A, Govekar R. Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method.J Transl Med. 2019 May 31;17(1):184. doi: 10.1186/s12967-019-1937-9.
4. Patil V,Joshi A,Noronha V,Agarwala V,Chougule A,Kanan S, Bhattacharjee A, Chandrasekharan A, Pande N, Simha V, Goud S, More S, Kumar R, Mahajan A, Janu A, Purandare N, Prabhash K.Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer.Oncotarget. 2019 Oct 29;10(59):6297-6307. doi: 10.18632/oncotarget.27214. eCollection 2019 Oct 29.
5. Singhavi HR, Chakrabarti S, Singh A, Mair M, Bhattacharjee A, Shetty R, Qayyumi B, Pai A, Joshi P, Nair D, Nair S, Chaturvedi P.Comparison of the 7th and 8th edition AJCC classification system in oral cavity squamous cell cancers.Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32720. [2019M.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4886734/2019M.pdf)

6. Vijay Patil, Vanita Noronha, Amit Joshi, Anuradha Chougule, Atanu Bhattacharjee, Alok Goel, Vikas Talreja, Nandini Menon, Anant Ramaswamy, Ashay Karpe, Nikhil Pande, Arun Chandrasekharan, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Kumar Prabhash.
Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/ carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer.Cancer Research,Statistics and Treatment.2019 2(1).21-27.
7. Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N,Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A,Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R,Vallathol DH, Dsouza H, Shrirangwar S,Turkar S, Abraham G, Thanky AH,Patel U,Pandey MK,Prabhash K.A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.Cancer. 2019 Sep 15;125(18):3184-3197. doi: 10.1002/cncr.32179. Epub 2019 May 31.
8. Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, Yadav A,
Trivedi V, Behel V, Dutt A, Banavali SD, Prabhash K.Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.J Clin Oncol. 2019 Aug 14:JCO1901154. doi: 10.1200/JCO.19.01154.
9. Bhattacharjee A.Bayesian competing risks analysis without data stratification.Clinical Epidemiology and Global Health (In press) 2019.
10.Mukesh Kumar  Prashant Kr. Sonker  Agni Saroj  Aanchal Jain  Atanu Bhattacharjee  Rakesh Kr. Saroj.
Cancer Reports.Parametric survival analysis using R: Illustration with lung cancer data.2019. https://doi.org/10.1002/cnr2.1210
11. Bhattacharjee A.A joint longitudinal and survival model for dynamic treatment regimes in Presence of Competing Risk Analysis.
Clinical Epidemiology and Global Health.2019.7(3).337-341.
12. Bhattacharjee A,Budukh A,Dikshit  R.Prostate cancer survival estimates: An application with piecewise hazard function derivation.South Asian journal of cancer.2019.8(3).105.[SouthAsianJCancer83150-4324212_120042.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4890472/SouthAsianJCancer83150-4324212_120042.pdf)

13. A Bhattacharjee, GK Vishwakarma.Time-course data prediction for repeatedly measured gene expression.International Journal of Biomathematics.2019.12(4).[bhattacharjee2019.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4882223/bhattacharjee2019.pdf)

14. Vijay M Patil, Arun Chandrasekharan, Dilip Harindran Vallathol, Mridul Malhotra, Ram Abhinav, Priti Agarwal, Anu Rajpurohit, Raees Tonse, Atanu Bhattacharjee, Rakesh Jalali. Antiemetic prophylaxis with temozolomide: an audit from a tertiary care center.2019.Neuro-Oncology Practice.4(19).[20200708171912.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4890407/20200708171912.pdf)

15. Atanu Bhattacharjee, Gaurav Roy, Atul Budukh, Rajesh Dikshit, Vijay M Patil, Amit Joshi, Vanita Noronha, Kumar Prabash, Papai Roy A competing risk analysis of death patterns in male genitourinary cancer.(2019).Cancer Reports, e1174.[cnr2.1174.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4890400/cnr2.1174.pdf).

16.Vanita Noronha,Vijay Maruti Patil,Amit Joshi,Nandini Menon,Anuradha Chougule,Abhishek Mahajan,Amit Janu,Nilendu Purandare,Rajiv Kumar,Sucheta More,Supriya Goud,Nandkumar Kadam,Nilesh Daware,Atanu Bhattacharjee,Srushti Shah,Akanksha Yadav, Vaishakhi Trivedi, Vichitra Behel,Amit Dutt,hripad Dinanath Banavali,and Kumar Prabhash.Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.[noronha2019.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4890867/noronha2019.pdf)


## [2018]
 
1.Atanu Bhattacharjee,Gajendra K. Vishwakarma,Abin Thomas.Bayesian state-space modeling in gene expression data analysis: An
application with biomarker prediction.2018;Mathematical Biosciences.2018 Nov;305:96-101. doi: 10.1016/j.mbs.2018.08.011. Epub 2018 Sep 5.[2018A.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4882333/2018A.pdf)


2.Vijay Patil, Amit Joshi, Vanita Noronha, Atanu Bhattacharjee1, Sachin Dhumal, M. V. Chandrakanth, Ashay Karpe,
Vikas Talreja, Arun Chandrasekharan, Siddharth Turkar, Nikhil Pande, Anant Ramaswamy, Kumar Prabhash. Quality of life and quality‑adjusted time without toxicity in palliatively treated
head‑and‑neck cancer patients.South Asian J Cancer
2018;7:249-53.[2018B.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716509/2018B.pdf).

3.Vanita Noronha,Avinash Pandey,Vijay Patil,Amit Joshi,Anuradha Bharat Choughule,Atanu Bhattacharjee,Rajiv Kumar,Supriya Goud,Sucheta More,Anant Ramaswamy,Ashay Karpe,Nikhil Pande, Arun Chandrasekharan,Alok Goel, Vikas Talreja, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Kumar Prabhash.Tyrosine Kinase Inhibitor versus Physician Choice Chemotherapy in
Second‑Line Epidermal Growth Factor Receptor Mutation Non‑Small Cell
Lung Cancer: Post hoc Analysis of Randomized Control Trial.Indian Journal of Medical and Paediatric Oncology.2018;39(4).493-498.[2018C.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716510/2018C.pdf).

4.Biju Menon,Atanu Bhattacharjee,Sandip Basu.Comparison of Radioiodine uptake by Gamma Camera and
Thyroid uptake probe‐based methodologiesand Diagnostic
Radioiodine Scanin Differentiated thyroid carcinoma.J of Nuclear Medicine Technology, doi:10.2967/jnmt.118.207837.[2018D.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716512/2018D.pdf).

5.Vijay M. Patil, Mridul Malhotra, Raees Tonse, Jayita Deodhar, Arun Chandrasekharan,
Nikhil Pande, Atanu Bhattacharjee, and Rakesh Jalali.A cross-sectional audit of distress in patients
undergoing adjuvant therapy or follow-up in central
nervous system malignancies.Neuro-Oncology Practice.Neuro-Oncology Practice, Volume 6, Issue 4, August 2019, Pages 305–310, https://doi.org/10.1093/nop/npy046.[2018E.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716514/2018E.pdf).

6.Patil V, Joshi A, Noronha V, Dhumal S,
Chandrasekharan A, Pande N, et al. Quality of life without toxicity or
symptoms analysis of a randomized controlled clinical trial comparing
efficacy of cabazitaxel versus docetaxel in recurrent head and neck cancer.
Cancer Res Stat Treat 2018;1:46-50.[2018F.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716515/2018F.pdf).

7.Bhattacharjee A, Vishwakarma GK, Banerjee S.
A Bayesian approach for dynamic treatment regimes in the presence of
competing risk analysis. Cancer Res Stat Treat 2018;1:51-7.[2018G.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716516/2018G.pdf).

8.Influence of Hypothyroidism After Chemoradiation on Outcomes in
Head and Neck Cancer.Clinical Oncology xxx (2018) 1.[2018H.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716519/2018H.pdf).

9.Atanu Bhattacharjee,Vijay M. Patil,Vanita Noronha,Amit Joshi,Kumar Prabhash.An Algorithm to Define the Optimum Biological Dose
of Metronomic Chemotherapy.Biometrical Letters
Vol. 0 (2018), No. 0, xx-xx.[2018I.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716520/2018I.pdf).

10. Nair CK, Raghavan V, Bhattacharjee A, Kurup AR. Impact of early reduction in paraprotein on survival in transplant ineligible myeloma: Lesson from a tertiary cancer center in rural India.[2018J.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4793314/2018J.pdf)

11.Amit Joshi, Vijay Patil, Vanita Noronha, Anuradha Chougule, Atanu Bhattacharjee, Rajiv Kumar, Supriya Goud, Sucheta More, Anant Ramaswamy, Ashay Karpe, Nikhil Pande, Arun Chandrasekharan, Alok Goel, Vikas Talreja, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Kumar Prabhash: Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?. Lung India 01/2018; 35(1):27., DOI:10.4103/lungindia.lungindia_201_17. [2018K.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716521/2018K.pdf)

12.Gaurav Roy, Papai Roy, Atanu Bhattacharjee, Mudassar Shahid, Mohammad Misbah, Subash Gupta, Mohammad Husain. Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma.The International Journal of Biological Markers.2018, Vol. 33(3) 283–292.[2018L.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4741389/2018L.pdf)


## [2017]

1.Joshi A, Tandon N, Patil VM, Noronha V, Gupta S, Bhattacharjee A, et al. Agreement analysis between three
different short geriatric screening scales in patients undergoing chemotherapy for solid tumors. J Can Res Ther 2017;13:1023-6.[2017A.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764006/2017A.pdf).

2.Amit Joshia,Vijay Patila,1, Vanita Noronhaa, Sachin Dhumala, Nikhil Pandea,Arun Chandrasekharana, Siddharth Turkara, Hollis DSouzaa, Sameer Shrirangwara,Abhishek Mahajanb, Supreeta Aryab, Shashikant Juvekarb, Atanu BhattaCharjeec,Kumar Prabhasha,⁎Results of a phase II randomized controlled clinical trial comparing efficacyof Cabazitaxel versus Docetaxel as second line or above therapy in recurrent
head and neck cancer.Oral Oncology 75 (2017) 54–60.[2017B.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764007/2017B.pdf).

3.Noronha V, Patil VM, Joshi A, Bhattacharjee A, Paul D,
Dhumal S, et al. A tertiary care experience with paclitaxel and cetuximab as
palliative chemotherapy in platinum sensitive and nonsensitive in head and
neck cancers. South Asian J Cancer 2017;6:11-4.[2017C.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764008/2017C.pdf)

4.Niranjan Gopal,Bidhan Chandra Koner,Atanu Bhattacharjee,Vishnu Bhat, Sathish Babu,Murugaiyan, Prakash H. Muddegowda.Assay of Urinary Protein Carbonyl Content Can Predict the Steroid Dependence and Resistance in Children with Idiopathic Nephrotic
Syndrome.Saudi J Kidney Dis Transpl 2017;28(2):268-272[2017D.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764009/2017D.pdf)

5.Atanu Bhattacharjee,Jesna Jose,Gajendra K. Vishwakarma,Ramesh Kumar.Joint modeling of missing and mismeasured measurements for computing radiotherapy margins[2017E.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764011/2017E.pdf)

6.Atanu Bhattacharjeea,Tapesh Bhattacharyya,Sanjana Santhosh,P. Kiran,V.P. Sanudev Sadanandan,M. Geetha.Impact of waiting time for treatment on survival in patients undergoing radiotherapy for head and neck cancer.Journal of Cancer Policy 13 (2017) 1–4[2017F.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764012/2017F.pdf)

7.A. Bhattacharjee, et al., Human epidermal growth factor receptor 2 borderline mortality in breast cancer
patients: Evidence from surveillance, epidemiology, and end results program population-based study, Clin Epidemiol Glob Health (2018),
https://doi.org/10.1016/j.cegh.2017.12.005.[2017G.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764013/2017G.pdf)

8.Joshi A, Bhattacharjee A, Noronha V, Patil V M, Karpe A, Kadam N, Solanki L, Prabhash K. Development and validation of a
predictive score, for identifying poor eastern cooperative oncology group performance status (performance status 3–4) advanced
nonsmall cell lung cancer patients who are likely to benefit from tyrosine kinase inhibitors.Indian J Cancer 2017;54:127-131.[2017H.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764014/2017H.pdf)

9.Vanita Noronha,Vijay Patil1,Amit Joshi1, Anuradha Chougule,Atanu Bhattacharjee,Rajiv Kumar, Sucheta More,Supriya
Goud, Ashay Karpe, Anant Ramaswamy, Nikhil Pande, Arun Chandrasekharan, Alok Goel, Vikas Talreja, Abhishek
Mahajan, Amit Janu, Nilendu Purandare and Kumar Prabhash.Impact of exon 19 versus exon 21 EGFR-activating mutation on
outcomes with upfront pemetrexed–carboplatin chemotherapy[2017I.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764015/2017I.pdf)

10.Joshi A, Patil VM, Noronha V, Ramaswamy A,
Gupta S, Bhattacharjee A, et al. EMERALD: Emergency visit audit of patients
treated under medical oncology in a tertiary cancer center: Logical steps to
decrease the burden. South Asian J Cancer 2017;6:186-9.[2017J.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764016/2017J.pdf)

11.Amit Joshi,Vijay Patil,Vanita Noronha,Sachin Dhumal,Nikhil Pande,Arun Chandrasekharan,Siddharth Turkar,Hollis DSouza,Sameer Shrirangwar, Abhishek Mahajan, Supreeta Arya, Shashikant Juvekar, Atanu BhattaCharjee, Kumar Prabhash.
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.Oral Oncol
. 2017 Dec;75:54-60. [2017K.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764017/2017K.pdf)


12.Joshi A, Tandon N, Patil VM, Noronha V, Gupta S, Bhattacharjee A, et al. Agreement analysis between three
different short geriatric screening scales in patients undergoing chemotherapy for solid tumors. J Can Res Ther 2017;13:1023-6.[2017L.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764018/2017L.pdf)

13.Tapesh Bhattacharyya and Atanu Bhattacharjee.A New Index to Measure Intra-observer Variation in Delineating GTV Primary in Head and Neck Cancer.MOJ Cell Sci Rep. 2017;4(4):104‒108.[2017M.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764019/2017M.pdf)

14.Atanu B, Gajendra V, Jesna J and Ramesh V.Multiple Imputations for Determining an Optimum Biological Dose of a Metronomic Chemotherapy.Biostat Biometrics Open Acc J 3(5): BBOAJ.MS.ID.555621 (2017).[2017N.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764020/2017N.pdf)


15.Vijay M Patil,Vanita Noronh,Amit Joshi,Kumar Prabhash,Atanu Bhattacharjee.Bayesian relative survival : An illustration with lung cancer patients data.Journal of Statistics & Management Systems
Vol. 20 (2017), No. 3, pp. 325–336.[2017O.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764021/2017O.pdf)

16.Vanita Noronha, Amit Joshi, Vijay Maruti Patil, Jaiprakash Agarwal, Sarbani Ghosh-Laskar, Ashwini Budrukkar,
Vedang Murthy, Tejpal Gupta, Anil K. D’Cruz, Shripad Banavali, Prathamesh S. Pai, Pankaj Chaturvedi,
Devendra Chaukar, Nikhil Pande, Arun Chandrasekharan, Vikas Talreja, Dilip Harindran Vallathol,
Vijayalakshmi Mathrudev, Aparna Manjrekar, Kamesh Maske, Arati Sanjay Bhelekar, Kavita Nawale, Sadhana
Kannan, Vikram Gota, Atanu Bhattacharjee, Shubhada Kane, Shashikant L. Juvekar, and Kumar Prabhash.Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.J Clin Oncol
. 2018 Apr 10;36(11):1064-1072.[2017P.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4764022/2017P.pdf).

17.Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer.[2017Q.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4793381/2017Q.pdf)

18.Comparison of paclitaxel-cetuximab chemotherapy versus metronomic chemotherapy consisting of methotrexate and celecoxib as palliative chemotherapy in head and neck cancers.

19.Atanu B,Savanur S and Suman K.Risk-Based Monitoring in Clinical Trial: An Application with Neural Networking.Biostat Biometrics Open Acc J 3(5): BBOAJ.MS.ID.555524 (2017).[2017S.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4793434/2017S.pdf)


20.Atanu Bhattacharjee,Gajendra Vishwakarma,Abin Thomas.Detecting Diagnostic Accuracy of Biomarkers Through a Bivariate Beta Distribution.[2017T.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4793478/2017T.pdf)


21.A Novel Model to Predict Tumour Recurrence in Hepatitis B Virus Associated Hepatocellular Carcinoma.[2017U.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4793483/2017U.pdf)


22.Jaiprakash Aggarwal,Santam Chakraborty,Sarbani Ghosh Laskar,Vijay M. Patil,Kumar Prabhash,Atanu Bhattacharjee,Vanita Noronha,Nilendu C. Purandare,Amit Joshi,Naveen Mummudi,Jitendra Arora,Rupali Badhe.Reference Data for Standardized Quality of Life Questionnaires in Indian Patients with Brain Metastases from Non-small Cell Lung Cancer: Results from a Prospective Study.Cureus 9(4): e1149. DOI 10.7759/cureus.1149[2017V.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4793495/2017V.pdf)


24.Vijay Maruti Patil,Vanita Noronha,Amit Joshi,Anuradha Bharat Choughule,Atanu Bhattacharjee,Rajiv Kumar,Supriya Goud,Sucheta More,Anant Ramaswamy,Ashay Karpe,Nikhil Pande,Arun Chandrasekharan,Alok Goel,Vikas Talreja,Abhishek Mahajan,Amit Janu,Nilendu Purandare,Kumar Prabhash.Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma.ESMO Open 2017;2:e000168. doi:10.1136/esmoopen-2017-000168
.[2017W.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4793475/2017W.pdf)


25.Vijay M. Patil,Vanita Noronha,Amit Joshi,Anant Ramaswamy,Sachin Dhumal,Shashikant Juvekar,Supreeta Arya,Abhishek Mahajan,Pankaj Chaturvedi,Anil D’Cruz,Atanu Bhattacharjee,Kumar Prabhash.Neoadjuvant chemotherapy in geriatric head and neck cancers.HEAD & NECK—DOI 10.1002/HED MONTH 2017[2017X.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4793462/2017X.pdf)

26.Atanu Bhattacharjee,Vijay M Patil.Determining an optimum biological dose of a metronomic chemotherapy.Journal of Data Science 15(2017), 867-884 [2017Y.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4793449/2017Y.pdf)

27.Vijay M Patil, Vanita Noronh, Amit Joshi, Kumar Prabhash & Atanu Bhattacharjee.Bayesian accelerated failure time and its application in Chemotherapy drug treatment trial.Journal of Statistics & Management Systems Vol. 20 (2017), No. 3, pp. 325–336.[2017Z.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4793418/2017Z.pdf)

## [2016-2014]
1.VM Patil,S Chakraborty,TK Jithin, S Dessai, TP Sajith Babu,V Raghavan, M Geetha, T Shiva Kumar, MS Biji, A Bhattacharjee, C Nair.Development and validation of a questionnaire to measure preferences and expectations of patients undergoing palliative chemotherapy: EXPECT questionnaire.Indian Journal of Cancer.2016;53(2),339-344.[2016A.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716367/2016A.pdf).

2.SB Dessai,VM Patil,S Chakraborty,S Babu,A Bhattacharjee,S Nayanar,S Vikram, S Balasubramanian.An audit of cytoreductive surgeries in ovarian cancer from a rural based cancer center.Indian Journal of Cancer.2016;53(2),284-287.[2016B.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716368/2016B.pdf).

3.VM Patil,S Chakraborty,TK Jithin,S Dessai,TP Sajith Babu,V Raghavan,M Geetha,T Shiva Kumar,MS Biji,A
Bhattacharjee, C Nair.Development and validation of a questionnaire to measure preferences and
expectations of patients undergoing palliative chemotherapy: EXPECT questionnaire.Indian Journal of Cancer.2016;53(2),339-344.[2016C.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716369/2016C.pdf).

4.Vijay M. Pati, Vanita Noronha, Amit Joshi, Saurabh Zanwar, Anant Ramaswamy, Supreeta Arya, Abhishek Mahajan,
Atanu Bhattacharjee, Kumar Prabhash.Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy
in head and neck cancers: Myth or reality?[2016D.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716370/2016D.pdf).

5.Atanu Bhattacharjee,Vijay M. Patil.Time-Dependent Area Under the ROC Curve
for Optimum Biological Dose Detection.Turkiye Klinikleri J Biostat 2016;8(2):103-9.[2016E.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716371/2016E.pdf).

6.SB Dessai, S Chakraborty, TVS Babu, S Nayanar, A Bhattacharjee,J Jones,S Balasubramanian,VM Patil,Tolerance of weekly paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced
ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin.Indian Journal of Cancer.2016;53(2),280-283.[2016F.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716372/2016F.pdf).

7.Vijay M. Patil,Vanita Noronha,Amit Joshi,Vamshi Muddu,Sachin Dhumal,Atanu Bhattacharjee,Kumar Prabhash.Compliance With Neoadjuvant
Chemotherapy in T4 Oral Cancers:Place, Person, Socioeconomic Status, or
Assistance(2015).JGO – Journal of Global Oncology.1(2).[2016G.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716373/2016G.pdf).

8.Vijay Patil,Amit Joshi, Vanita Noronha,Jayita Deodhar,Atanu Bhattacharjee,Sachin Dhumal,M.V.K. Chandrakanth,Ashay Karpe,Vikas Talreja,
Arun Chandrasekharan,Siddharth Turkar,Anant Ramaswamy,Kumar Prabhash.Oral Oncology 63 (2016) 10–15.Expectations and preferences for palliative chemotherapy in head and neck cancers patients[2016H.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716374/2016H.pdf).

9.Ramesh K. Vishwakarma,Dilip C. Nath,Atanu Bhattaharjee.Working Correlation Structures:Application in Liver Cirrhosis
Therapeutic Effect Trial.Turkiye Klinikleri J Biostat 2016;8(2):116-24.[2016I.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716375/2016I.pdf).

10.Dilip C. Nath, Ramesh K. Vishwakarma, Atanu Bhattacharjee.A selection modelling approach to analysing missing data
of liver Cirrhosis patients.Biometrical Letters
Vol. 53 (2016), No. 2, 83-103[2016J.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716378/2016J.pdf).

11.Niranjan Gopal,Bidhan Chandra Koner,Atanu Bhattacharjee, Vishnu Bhat.Assay of Urinary Protein-Bound Sialic Acid can Differentiate Steroid-Sensitive Nephrotic Syndrome from Steroid-Resistant Cases.Saudi J Kidney Dis Transpl 2016;27(1):37-40.[2016K.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4716379/2016K.pdf)

12.Efficacy of second-line erlotinib in patients postprogression of first-line chemotherapy in
head and neck cancers.2015;52(4).629-631.[2015A.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4715124/2015A.pdf)

13.S. Kane,V.M. Patily,A. Joshi,V. Noronha,V. Muddu,S. Dhumal,S. Juvekar,S. Arya,A. D’Cruz,A. Bhattacharjee,K. Prabhash.[2015B.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4715125/2015B.pdf)

14.Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers:
Does Human Papillomavirus Make a Difference?Clinical Oncology xxx (2015) 1e2.[2015C.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4715128/2015C.pdf)

15.Dilip C Nath,Atanu Bhattacharjee and Ramesh K Vishwakarma.The Cure Rate Modeling: An Application with Bayesian approach in Liver
Cirrhosis Patients.Journal of Data Science 13(2015), 421-442.[2015D.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4715129/2015D.pdf)

16.Atanu Bhattacharjee,and Tapesh Bhattacharyya.Bayesian Concordance Correlation Coefficient with Application to Repeatedly Measured Data.Turkiye Klinikleri J Biostat 2015;7(2):55-62 [2015E.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4715130/2015E.pdf).

17.Atanu Bhattacharjee and Santam Chakraborty."In regard to Livi et al. “Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5 year survival analysis of a phase 3 randomised controlled trial".European Journal of Cancer (2015) 51, 1476– 1477.[2015F.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4715132/2015F.pdf)

18.Atanu BhattacharjeeDistance Correlation Coefficient: An Application with Bayesian Approach in Clinical Data Analysis.Journal of Modern Applied Statistical Methods 2014;13(1):354-366.[2014A.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4715052/2014A.pdf)

19.Atanu Bhattacharjee, and Subhradev Sen.Letter to the editor: Second, third, and fourth head and neck tumors. A progressive
decrease in survival.Head & Neck 36: 1376, 2014.[2014B.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4715056/2014B.pdf)

20.Atanu Bhattacharjee and Dilip C. Nath.Joint Longitudinal and Survival Data Modeling: An Application inAnti-Diabetes Drug Therapeutic Effect. Statistics in Transition new series.2014;15(3).437-452.
[2014C.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4715058/2014C.pdf)

### [2013-2012]
21.Bhattacharjee Atanu,and  Saikia Hemanta.An Application of Bootstrap Regression Method in Age Dependency Structure to the Community.
Indian Journal of Public Health Research & Development.2013;4(3).44-48.[2013A.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4715108/2013A.pdf)

22.Bhattacharjee A, Bhattacharjee D. A Bayesian Approach to Compare the Statewise Dengue Death Counts in India. International Journal of Collaborative Research on Internal Medicine & Public Health. 2011; 3(10):715-723.[20200602100511.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4714786/20200602100511.pdf)

23.Dilip C. Nath and Atanu Bhattacharjee. Comparison of the tetrachoric correlation coefficients and odds in generalized estimating equation with Bayesian approach: an application in type 2 diabetes patients data.2011;5(2):97-108.
[20200602101224.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4714806/20200602101224.pdf).

24.Hemanta Saikia,Dibyojyoti Bhattacharjee,and Atanu Bhattacharjee.Is IPL responsible for cricketers’ performance in Twenty20 World Cup?
International Journal of Sports Science and Engineering.2012;6(02):096-110.[20200602102234.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4714831/20200602102234.pdf)

25.Dilip C. Nath and Atanu Bhattacharjee.Effect of Correlation Structure in Generalized Estimating Equation and Quasi Least Square: An Application in Type 2 Diabetes Patient. Pak.j.stat.oper.res.2011.VII(2).401-412.
[20200602102044.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4714821/20200602102044.pdf)

26.A Bayesian Approach for Autoregressive Models in Longitudinal Data Analysis: An Application to Type 2 Diabetes Drug Comparison.[20200602101832.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4714820/20200602101832.pdf)

### Biostatistics Tutorial
1. Introduction to Biostatistics
[1546938553M1.pdf](https://github.com/atanustat/biostatonco/files/4000779/1546938553M1.pdf)
2. Survival Analysis
[Survival Analysis.pdf](https://github.com/atanustat/biostatonco/files/4000798/Survival.Analysis.pdf)
3. Parametric survival analysis
[parametric survival analysis.pdf](https://github.com/atanustat/biostatonco/files/4000800/parametric.survival.analysis.pdf)
4. Acturial estimator with R
[Acturial estimator with R.pdf](https://github.com/atanustat/biostatonco/files/4000801/Acturial.estimator.with.R.pdf)
5. Kaplan Meier Estimators-I
[Kaplan Meier Estimators-I.pdf](https://github.com/atanustat/biostatonco/files/4000802/Kaplan.Meier.Estimators-I.pdf)
6. Kaplan Meier Estimators-II
[Uploading Kaplan Meier Estimators-Ii.pdf…]()
7. Nelson aalen estimator
[nelson aalen estimator.pdf](https://github.com/atanustat/biostatonco/files/4001281/nelson.aalen.estimator.pdf)
8. Equality of survival
[equality of survival function.pdf](https://github.com/atanustat/biostatonco/files/4001282/equality.of.survival.function.pdf)
9. Mantel Haenszel Estimator
[Mantel-Haenszl Estimators.pdf](https://github.com/atanustat/biostatonco/files/4001284/Mantel-Haenszl.Estimators.pdf)
10. Cox PH Model
[Cox PH model.pdf](https://github.com/atanustat/biostatonco/files/4001285/Cox.PH.model.pdf)

11. Estimation and Inference for Cox’s [Estimation and Inference for Cox’s.pdf](https://github.com/atanustat/biostatonco/files/4001298/Estimation.and.Inference.for.Cox.s.pdf)
12. Diagnostics for Cox’s PH model [Diagnostics for Cox’s PH model.pdf](https://github.com/atanustat/biostatonco/files/4001299/Diagnostics.for.Cox.s.PH.model.pdf)
13. The Accelerated Failure Time [The Accelerated Failure Time.pdf](https://github.com/atanustat/biostatonco/files/4001300/The.Accelerated.Failure.Time.pdf)
14. Competing Risks Model [Competing Risks Model.pdf](https://github.com/atanustat/biostatonco/files/4001301/Competing.Risks.Model.pdf)
15. Clinical Trials [Clinical Trials.pdf](https://github.com/atanustat/biostatonco/files/4001302/Clinical.Trials.pdf)
16. Sample size determination
[sample size determination.pdf](https://github.com/atanustat/biostatonco/files/4001312/sample.size.determination.pdf)
17. Random Allocation
[random allocation.pdf](https://github.com/atanustat/biostatonco/files/4001314/random.allocation.pdf)
18. Sequential Clinical Trial-I
[sequential clinical trial.pdf](https://github.com/atanustat/biostatonco/files/4001315/sequential.clinical.trial.pdf)
19. Sequential Clinical Trial-II
[sequential clinical trial II.pdf](https://github.com/atanustat/biostatonco/files/4001316/sequential.clinical.trial.II.pdf)
20. Sequential Clinical Trial-III
[sequential clinical trial III.pdf](https://github.com/atanustat/biostatonco/files/4001318/sequential.clinical.trial.III.pdf)
21. Randomize play the winder rule
[Randomize play the winder rule.pdf](https://github.com/atanustat/biostatonco/files/4001329/Randomize.play.the.winder.rule.pdf)
22. The Play the Winnder Rule [The Play the Winnder Rule.pdf](https://github.com/atanustat/biostatonco/files/4001331/The.Play.the.Winnder.Rule.pdf)
23. Crossover Trial[Crossover trial.pdf](https://github.com/atanustat/biostatonco/files/4001332/Crossover.trial.pdf)
24. Introduction to Epidemiology[Introduction to Epidemiology.pdf](https://github.com/atanustat/biostatonco/files/4001333/Introduction.to.Epidemiology.pdf)
25. Disease Frequency[Disease Frequency-I.pdf](https://github.com/atanustat/biostatonco/files/4001335/Disease.Frequency-I.pdf)
26. Disease Frequency-II[Disease Frequency-II.pdf](https://github.com/atanustat/biostatonco/files/4001354/Disease.Frequency-II.pdf)
27. Disease Frequency-III[Disease Frequency-III.pdf](https://github.com/atanustat/biostatonco/files/4001358/Disease.Frequency-III.pdf)
28. Observational Study[Observational Study.pdf](https://github.com/atanustat/biostatonco/files/4001360/Observational.Study.pdf)
29. Analystical Study[Analytical Study.pdf](https://github.com/atanustat/biostatonco/files/4001353/Analytical.Study.pdf)
30. Case Control Study[Case Control Study.pdf](https://github.com/atanustat/biostatonco/files/4001352/Case.Control.Study.pdf)
31. Cohort Study-I [Cohort Study -I.pdf](https://github.com/atanustat/biostatonco/files/4001350/Cohort.Study.-I.pdf)
32. Cohort Study-II [Cohort Study-II.pdf](https://github.com/atanustat/biostatonco/files/4001349/Cohort.Study-II.pdf)
33.  Case Control Study -I[case Control Study -I.pdf](https://github.com/atanustat/biostatonco/files/4001346/case.Control.Study.-I.pdf)
34.  Case Control Study -II[Case Control Study II.pdf](https://github.com/atanustat/biostatonco/files/4001343/Case.Control.Study.II.pdf)
35. Confounding[confounding.pdf](https://github.com/atanustat/biostatonco/files/4001342/confounding.pdf)
36. Stratified Analysis[Stratified Analysis.pdf](https://github.com/atanustat/biostatonco/files/4001340/Stratified.Analysis.pdf)
37. Matched Analysis-I[Matched Analysis-I.pdf](https://github.com/atanustat/biostatonco/files/4001337/Matched.Analysis-I.pdf)
38.  Matched Analysis-I[Mathced Analysis-II.pdf](https://github.com/atanustat/biostatonco/files/4001336/Mathced.Analysis-II.pdf)
39. Lung Cancer Update 2019 [presentation.pdf](https://github.com/atanustat/biostatonco/files/4002993/presentation.pdf).
40. Computational Biostatistics and Survival Analysis Talk[cce presentation.pdf](https://github.com/atanustat/biostatonco/files/4002995/cce.presentation.pdf).
41. Hands on Survival Analysis Researchers.(https://github.com/atanustat/biostatonco/files/4710190/AB1011.Hands.on.Survival.Analysis.pdf)
### Contact
abhattacharjee@actrec.gov.in/atanustat@gmail.com   
Centre for Cancer Epidemiology, Tata Memorial Centre, Navi Mumbai,India


